CTOs on the Move

LuxCath

www.luxcath.com

 
LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.luxcath.com
  • 100 High Street 28th Floor
    Boston, MA USA 02110
  • Phone: 617.419.1800

Executives

Name Title Contact Details
Terry Ransbury
Chief Technology Officer Profile

Similar Companies

Joint Active Systems

Joint Active Systems is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metro Optics Inc

Metro Optics Inc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthStrategiesGroup

HealthStrategiesGroup is a Lambertville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Total Contact

Total Contact is a Germantown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Skytron

Skytron is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.